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Pax6 is a transcription factor with an essential role in eye, central nervous system, and pancreas development. Its expression pattern is
restricted to these specific domains within the developing embryo. Here four conserved elements are identified in Pax6 intron 7, showing a
high level of sequence conservation between human, mouse, pufferfish, and zebrafish. Three of these are shown to act as cis-regulatory
elements, directing expression of a reporter gene to distinct subsets of the Pax6 expression domain. CE1 regulates gene expression in late eye
development, CE2 drives expression in the diencephalon and in the developing heart tube where Pax6 is not normally expressed, while CE3
directs expression in rhombencephalon. CE2 is shown to be autoregulated in the diencephalon, responding to absence of Pax6. We identify a
highly conserved Pax6 recognition site and demonstrate its ability to bind Pax6 specifically. CE1 is embedded in a CpG island, and we
identify a novel Pax6 transcript which initiates from this region. Functional analysis of evolutionary conserved sequences pinpoints novel cis-
acting elements that govern the regulation of the complex spatio-temporal and quantitative expression of Pax6.
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PAX6, a member of the PAX (paired box) gene family of
developmental regulator genes, plays a central role in the
development of the eye, olfactory system, pancreas, and
central nervous system (CNS). The gene is highly conserved
at functional and sequence levels in all vertebrates; the DNA
binding domains share around 80% amino acid identity
from nematodes and flies to man.
The importance of Pax6 is especially evident from its
effects on eye morphogenesis. Homozygosity for loss-of-
function mutations in Pax6 leads to the absence of eyes in a
variety of species, while in heterozygotes, Pax6 haplo-
insufficiency leads to a number of ocular abnormalities, as
exemplified by the Smalleye mouse mutant (Hill et al.,
1991; Hogan et al., 1988), and the human eye defect aniridia
(Glaser et al., 1992; Jordan et al., 1992). The importance of
gene dosage for correct eye development is further demon-0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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vervan@hgu.mrc.ac.uk (V. van Heyningen).strated by the fact that overexpression of the gene via YAC
transgenesis also leads to eye malformations in mice (Schedl
et al., 1996). In Drosophila, misexpression of the eyeless
gene in imaginal disc primordia can lead to the formation of
ectopic eyes (Halder et al., 1995). This activity can be
mimicked by Pax6 from other species (Glardon et al.,
1997; Tomarev et al., 1997), indicating that the ability of
Pax6 to act as a master regulator for eye development is
conserved through evolution (Gehring, 1996).
Despite a wealth of data on the conservation of Pax6
sequence and function across a large number of species,
relatively little is known about the molecular mechanisms
that direct the expression of Pax6. The spatio-temporal
expression pattern of the gene has been studied in great
detail (Quinn et al., 1996; Stoykova and Gruss, 1994;
Walther and Gruss, 1991). Expression of PAX6 is not only
found in all structures of the developing eye, but also in
specific regions in the brain, the ventral neural tube, the
olfactory bulb and epithelium and pancreas (Walther and
Gruss, 1991). Cis-acting elements that drive Pax6 expres-
sion in some of these structures were first studied in quail,
where it was established that two alternative promoters are
used (Plaza et al., 1995b). A highly conserved element
was identified in intron 4 of the gene, which specifically
Fig. 1. Conserved elements in intron 7 of Pax6. (A, top) Diagram of the Pax6 genomic locus. Exons are indicated by grey boxes, and the positions of three known
promoters (P0, P1, and a) are indicated. Bars underneath the locus indicate the positions of CpG-rich regions. (A, middle) Intron 7 is shown enlarged and the
positions of four highly conserved sequence elements (CE1–4) are indicated. (A, bottom) VISTA plot of the inter-species comparison for the full intron 7
sequences of mouse, human, cow, pufferfish, and zebrafish. All sequences entered run from the start of exon7 to the end of exon8. Both zebrafish Pax6 genes,
Pax6a and Pax6b, are included in the plot. Mouse sequence was used as the base line against which the other species were pairwise compared, and is represented
on the x-axis. The y-axis represents percentage identity. The parameters used select contiguous subsegments of 50 bp length and a minimum of 70% identity. The
double arrow at the position of CE1 in the cow/mouse comparison signifies a gap in the known bovine sequence. Comparison between mammalian species
identifies the presence of four highly conserved regions. Element CE4 is absent in the three fish pax6 genes, while element CE2 is not found in zebrafish Pax6b.
(B) Table showing length and level of conservation to mouse sequence for each of the four conserved elements (CE1–4) in each species.
D.A. Kleinjan et al. / Developmental Biology 265 (2004) 462–477 463drives Pax6 expression in the neural retina, iris, and ciliary
body (Plaza et al., 1995a). More recently, a number of
studies have identified regulatory elements in the 5Vregion
of the murine gene, including elements for expression in
the lens (Williams et al., 1998), retina, pancreas, telen-
cephalon, and neural tube (Kammandel et al., 1999; Xu et
al., 1999). In addition, we have shown that several
essential control elements are found in a region stretching
>150 kb downstream of the gene, indicating that PAX6 is
subject to complex regulation involving both short- and
long-range control elements (Griffin et al., 2002; Kleinjan
et al., 2001).
Despite the identification of many cis-regulatory ele-
ments, the full pattern of Pax6 expression is still not fully
accounted for. Definition of a far-downstream elementcontrolling lens expression (Kleinjan et al., 2001), in
addition to a previously characterised upstream lens en-
hancer (Williams et al., 1998), shows that some Pax6
expression sites are controlled through multiple enhancer
elements (Treisman and Lang, 2002). Two distinct control
elements were also recently identified for the prosomere
P1 region of the diencephalon (Griffin et al., 2002;
Kleinjan et al., 2001).
Because Pax6 plays a central role in the regulatory
network for correct eye and brain development, it is of
interest to identify all regulatory elements involved in Pax6
transcriptional control. Comparing the genomic Pax6 se-
quence from human and Fugu (Miles et al., 1998) identified
three novel conserved elements in intron 7 of the gene.
Extending the comparison to mouse and the two zebrafish
Fig. 2. Developmental expression analysis of the LacZ reporter gene in transgenic lines carrying full mouse intron 7 sequences (7CE1234-Z). (A) X-gal-stained
E8.5 embryos show expression in the developing heart tube, diencephalon, and rhombencephalon. (B) Initial expression in the hindbrain is in a rhombomere
specific pattern with expression in rhombomeres 3 and 5 (arrows) appearing stronger before the other rhombomeres. (C) At E8.5, expression is seen throughout
the length of the primitive heart tube. (D) RNA in situ on E8.5 embryos showing the early rhombomere specific expression of endogenous Pax6. (E) Staining in
E9.5 embryos is seen in diencephalon, rhombencephalon, and heart (ov, otic vesicle). (F) In the developing heart tube, staining is seen in the outflow tract (ot),
but is down-regulated in the primitive ventricle (pv). (G) At E10.5, staining occurs throughout the rhombencephalon (r) with the exception of rhombomere 1.
(H) The pattern at this stage forms a typical subset of the endogenous Pax6 expression pattern in diencephalon (d) and rhombencephalon, with a narrow stripe
of positive cells at the base of the midbrain (m) (t, telencephalon). (I) Staining in diencephalon (d) is observed in the P1 and P2 prosomeres, and excludes the
midline, consistent with the endogenous Pax6 pattern. (J) An embryo dissected in half through the midline shows maintenance of expression in diencephalon,
rhombencephalon, and heart at E13.5. (K) From E12.5, expression starts to appear in the (albino) eye (arrow). (L) Section through an E14.5 eye shows
expression in the proximal neuroretina (nr). (M,N) Sections through an E10.5 embryo show expression in the rhombomeres (r), diencephalon (d), and the atria
(a) and outflow tract of the heart (h), but not in the left ventricle (v). (O) At E14.5, staining in the heart can be seen most strongly around the outflow region
with lighter staining in the atria and right ventricle (ao, aorta; p, pulmonary artery; la, left atrium; lv, left ventricle; ra, right atrium; rv, right ventricle). (P) At
E18.5, expression in the heart is limited to a narrow ring around the base of the pulmonary and aortic arteries (arrow; l, lung).
D.A. Kleinjan et al. / Developmental Biology 265 (2004) 462–477464homologues, Pax6a and Pax6b (Nornes et al., 1998),
reveals three highly conserved elements present in all
species, while a fourth element with very strong sequence
similarity is present only in mammals. Using transgenic
reporter studies, we have assessed the complete intron 7
sequence, as well as its separate component elements, for
enhancer function. We demonstrate that three of the ele-
ments function as tissue specific enhancers. One of these is
shown to be subject to direct Pax6 autoregulation. Intron 7
lies within the Pax6 linker region between the paired
domain and the homeodomain. It harbours an intragenic
CpG island, which we identify as the initiation site of a
novel transcript comparable to similar N-terminally trun-
cated transcripts reported in quail (Carriere et al., 1993) and
in Caenorhabditis elegans (Zhang and Emmons, 1995)
Pax6 genes.Materials and methods
Comparative sequence analysis
BACs containing zebrafish pax6a and pax6b were
obtained by screening a RZPD Danio rerio BAC librarywith a probe derived from a pax6a EST, IMAGE clone
3722431 (AI723103). The identity of pax6a or pax6b
BACs was confirmed by Southern blotting. Genomic frag-
ments containing the full intron 7 of pax6a and pax6b
were PCR amplified from the BACs using the following
primers:pax6aforward 5V-GCATGTATGAAAAGCTGAG-
GATGCTGA-3V;
pax6areverse 5V-GTGTTCTCACCGCCTCCGTCT-
GACTGT-3V;
pax6bforward 5V-CGTCCGGGATGGTACCCTGG-
TACGTCT-3V;
pax6breverse 5V-TTTGTGTTTTCACCACCGTTGT-
CCTGT-3V.
The products were cloned into pGEM-T (Promega) and
fully sequenced. Accession numbers: AJ507427 (pax6a)
and AJ507428 (pax6b). The VISTA program (Mayor et al.,
2000) was used for evolutionary sequence comparison
with a window size of 50 bp and a minimal sequence
identity of 70% using sequences derived from Z95332
(human), AL512589, MMU292560, MMU292561,
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ferfish), and AJ507427, AJ507428 (zebrafish).
Cloning of mouse intron 7 reporter constructs
The reporter constructs used are based on a modified
p610 vector containing a hsp68-LacZ cassette (Kothary et
al., 1989). Inserts containing parts of Pax6 intron 7 were
subcloned from a 129/Sv mouse BAC. Cloning strategies
are available on request.
Generation and analysis of transgenic mice
Microinjection fragments were gel purified using the
Qiagen gel extraction kit. Microinjection was performed
according to standard procedures (Hogan et al., 1994).
Transgenic mice and embryos were identified by Southern
blot or by PCR using tail DNA and primer pairs specific for
LacZ (5V-GTTGCGCAGCCTGAATGGCG-3V and 5V-
GCCGTCACTCCAACGCAGCA-3V). LacZ staining of em-
bryos was as previously described (Kleinjan et al., 2001).
Electrophoretic mobility shift assay
Nuclear extracts were prepared from ARPE (Dunn et
al., 1996) and HT-29 (ATCC no. HTB-38) cell lines as
described (Andrews and Faller, 1991). Ten micrograms of
nuclear extract protein was added to the binding buffer
containing 10 mM Hepes (pH 7.4), 1 mM EDTA, 10%
glycerol, 100 mM NaCl, 2 mM DTT, 1 Ag/Al BSA, and 1
Ag poly (dI–dC). Double-stranded oligonucleotide probes
were end-labelled with [g-32P]ATP and T4 polynucleotide
kinase. Binding reactions were incubated at room temper-
ature for 30 min. A combination of monoclonal anti-Pax6
antibodies (Engelkamp et al., 1999) was used to assess the
presence of Pax6 protein in complex with the target
oligonucleotide. The protein–DNA complexes were re-
solved on a 6% non-denaturing polyacrylamide gel, which
was then dried and exposed to autoradiographic film.
Probe sequences used were as follows:
Pax6CON: 5V-AATTCGTGAACTCAAGCGTGAAA-
ATGG-3V and 5V-AATTCCATTTTCACGCTTGAGTT-
CACG-3V
CE2-oligo: 5V-GGCTTGCTTGTTTTCCGCCTCACT-
GATTAAGACACT-3V and 5V-GGAGTGTCTTAAT-
CAGTGAGGCGGAAAACAAGCAAG-3V
CE2mutated: 5V-GCTTGCTTGTTTTCTAAGCTTCT-
GATTAAGACACT-3V and 5V-GGAGTGTCTTAATCA-
GAAGCTTAGAAAACAAGCAAG-3V
EI-Z-oligo: 5V-GGCTCTTACAAAACATGAGGCGG-
GAACTACTCTGAC-3V and 5V-GGGTCAGAG-
TAGTTCCCGCCTCATGTTTTGTAAGAG-3V
EI-Z-artif: 5V-GGCTGTTACAAAACAAGCGTTAC-
TAACTACTCTGAC-3V and 5V-GGGTCAGAGTAGT-
TAGTAACGCTTGTTTTGTAAGAG-3VLoxP-oligo: 5V-CGTATAACTTCGTATAGCATACAT-
TATACGAAGTTATCTCGAGA-3Vand 5V-CGTCTCGA-
GATAACTTCGTATAATGTATGCTATACGAAGTTA-
TA-3V.
RNA extraction and mapping of the alternative Pax6
transcript
RNA was isolated, using TRI reagent (Sigma), from
Pax6-expressing cell lines CE11560 and ARPE, from
non-expressing control HT-29, and from E11.5 whole
mouse embryos. CE11560 is a lens epithelial cell line
immortalised using replication-deficient SV40-adeno hy-
brid virus (Andley et al., 1994), ARPE is derived from
retinal pigment epithelium (Dunn et al., 1996), and HT-29
is a colon carcinoma line (ATCC no. HTB-38). RT-PCR
was performed using AMV reverse transcriptase and
random hexamers for first strand synthesis. Specific
PCR primers used:
Pr049: 5V-AGATGGGCGCAGACGGCATG-3V;
Pr050: 5V-TAGATCTATTTTGGCTGCTAGTC-3V;
Pr087: 5V-GCGACCGTCGGTGCGGAATGG-3V;
Pr088: 5V-AGAACATAGAGGAACTTGGTAAG-3V;
Pr204: 5V-TCGTAATAGGTGTCAAGGCGAA-3V;
Pr205: 5V-AGATTACAAGCTTGGTTTGGTTTC-3V;
Pr247: 5V-CTTCCCAGTGTCCGTCCTATA-3V;
Pr248: 5V-GTACAAAGGATGCTTCTGTCA-3V;
Pr249: 5V-TGCTTGGGAAATCCGAGACAG-3V;
Pr261: 5V-TGAGCTCTCGGACCGGCT-3V;
Pr262: 5V-GGAACATTTCTACAGCTGTCTCCT-3V.
Primer extension analysis was performed according to a
standard protocol using primer Pr256: 5V-AGCAATTACA-
GAGCGACAGGA-3V.Results
Comparative sequence analysis
Comparative analysis using multiple sequence align-
ments has proved a useful method for identifying potential
regulatory elements (Elgar et al., 1996; Loots et al., 2000;
Meisler, 2001). The presence of three conserved regions in
intron 7 of PAX6 was first revealed by human–Fugu
comparison (Miles et al., 1998) (Fig. 1A). To provide better
insight into the mechanisms of Pax6 gene regulation during
mouse development, we subcloned and sequenced intron 7
of the murine gene. As expected, conservation levels be-
tween human and mouse are even more prominent (Fig. 1).
The analysis also identified a fourth element with high
sequence conservation between mouse and human, which
is absent from Fugu. To extend the comparison, we added
another fish species to the analysis. Interestingly, zebrafish
has two Pax6 homologues, pax6a and pax6b (Nornes et al.,
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duplication of chromosome segments in the zebrafish line-
age. The two paralogues are 95% identical to each other in
amino acid sequence (Nornes et al., 1998) and the intron/
exon structure is conserved. We subcloned and sequenced
intron 7 from both pax6a and pax6b (database accessions
AJ507427; AJ507428). Genomic sequence comparison be-
tween mouse and each zebrafish gene (Fig. 1) shows that
elements CE1 (Conserved Element 1) and CE3 are con-
served in both pax6a and pax6b, while element CE2 is
found only in pax6a. Element CE4 is not found in either
pax6a or pax6b. Comparisons between zebrafish and Fugu
do not reveal any fish specific conservation at the equivalent
position, suggesting that CE4 is a mammalian specific
element. High level CE4 conservation is also found in other
mammalian species such as cow (AC126230) and cat
(AC126927) (not shown). VISTA plots of pair-wise se-
quence comparisons for intron 7 using mouse as the base
sequence are shown in Fig. 1A. Fig. 1B shows the conser-
vation level and length of each element relative to the mouse
sequence. Note that the mammal-specific CE4 carries the
highest level of conservation of all the intron 7 elements.
Analysis of enhancer function for the intron 7 region in
transgenic mice
To test whether these conserved elements fulfil a role
as transcriptional regulators of Pax6, we assessed their
function as enhancers in transgenic mice. A fragment
containing the full murine intron 7 sequence was cloned
in front of a hsp68-LacZ expression cassette (Kothary et
al., 1989) and the resulting construct, 7CE1234-Z, was
microinjected into oocytes. A complex but reproducible
staining pattern was observed in the transgenic offspring.
Expression was consistently seen in the diencephalon,
rhombencephalon, spinal cord, eye (only after E12.5) and,
unexpectedly, in the heart of several independent trans-
genic lines and primary embryos. All sites of LacZ
reporter expression other than the heart mirror part of
the endogenous Pax6 expression pattern, confirming that
intron 7 contains regulatory elements capable of directing
expression in a Pax6-specific manner. No reporter ex-
pression was seen in other embryonic Pax6 expression
sites such as pancreas, telencephalon, or early eye struc-
tures. Although Pax6 is not normally expressed in the
heart, all expressing transgenic lines carrying the full
7CE1234-Z construct consistently show lacZ expression
in heart as described below. Spinal cord expression is
part of the normal Pax6 pattern, but we believe that here
it is probably due to the hsp68 minimal promoter used in
the reporter cassette, as this has been observed before for
this vector (Kleinjan et al., 1997; Kothary et al., 1989).
To study the spatiotemporal expression pattern driven
by the complete intronic region, we analysed lacZ staining
in a series of staged embryos between E8.5 and E18.5. At
E8.5, expression is present in the fore- and hindbrainregions of the neural tube and in the whole of the
developing heart tube (Figs. 2A–C). Early expression in
the hindbrain area is rhombomere specific with expression
in Rh3 and Rh5 appearing stronger and before the other
rhombomeres (Fig. 2B), as is the case for the endogenous
Pax6 gene (Fig. 2D). At E9.5, expression is found in all
rhombomeres from rh2 to rh8, but remains stronger in rh3
and 5 (Fig. 2E). In the forebrain, expression is found in the
diencephalon (Figs. 2E,F). Expression is also seen in the
heart tube, but is strongly down-regulated in the primitive
ventricle (Fig. 2F). At E10.5, expression is found through-
out the rhombencephalon with the exception of Rh1 (Fig.
2G). Expression in the diencephalon is limited to proso-
meres 1 and 2 (P1 and P2) (Figs. 2H,I). Diencephalon and
hindbrain expression are maintained beyond E13.5 (Fig.
2J). From E12.5 onwards, expression also appears in the
developing eye (Fig. 2K), specifically in the proximal part
of the retina (Fig. 2L).
At E10.5, heart expression is observed in the developing
atrial and outflow tract areas (Figs. 2M,N). In addition, some
staining is seen in the right ventricle at E14.5, while the left
ventricle is negative (Fig. 2O). Expression in the outflow
region is maintained through later stages of development, at
least up to E18.5, when it is seen as a ring of expression
around the base of the pulmonary and aortic arteries (Fig. 2P).
Characterisation of tissue-specific enhancers in intron 7
The 7CE1234-Z construct contains four distinct se-
quence-conserved elements; we set out to determine which
element is responsible for each component of the complex
expression pattern. A series of constructs containing subsets
of conserved elements was microinjected to generate trans-
genic lines or primary embryos (Fig. 3A). A heterozygous
Pax6 knock-in embryo, with the LacZ gene inserted in frame
into Pax6 (St Onge et al., 1997) (hereafter referred to as
Pax6/LacZ knock-in or Pax6+/ ) illustrates the endoge-
nous Pax6 expression pattern at E10.5 (Fig. 3B). The
pattern driven by the full intron 7 construct, 7CE1234-Z,
is shown for comparison (Fig. 3C). The pattern elicited by
7CE123-Z, encompassing CE1, CE2, and CE3, but lacking
CE4, is very similar to the expression controlled by the
complete intronic construct (Fig. 3D), indicating that ele-
ments CE1, CE2, and CE3 account for the full activity of
intron 7. However, when CE3 is deleted, to produce
construct 7CE12-Z, rhombencephalon expression is lost,
while in diencephalon and heart, it is maintained (Fig. 3E).
Late eye expression (>E12.5) also remains unaltered (inset,
Fig. 3E). Rhombencephalon, diencephalon, and heart ex-
pression were found in E10.5 transient transgenic embryos
for construct 7CE23-Z, lacking CE1 (Fig. 3F). Finally,
CE1, CE2, and CE3 were assessed on their own for
independent function as tissue-specific enhancers. The
results confirm that CE2 drives expression in diencephalon
and heart (Fig. 3G). 7CE3-Z (not shown) and 7CE34-Z
(Fig. 3H) give identical results indicating that CE3 drives
Fig. 3. Identification of the cis-regulatory elements controlling transgene expression in the diencephalon, heart, rhombencephalon, and eye. (A) The mouse
genomic region containing intron 7 is shown at the top. Differently coloured and shaped boxes indicate the position of the four conserved elements (CE1–4).
The reporter constructs used to make transgenic lines or primary transgenic embryos are shown below, followed by a summary table of the expression sites
observed. (B–I) A representative embryo (aged E10.5, E11.5, or E14.5 (I)) for each of the constructs is shown. The name of the construct is shown below each
embryo. (B) Pax6+/ embryo in which LacZ reflects endogenous Pax6 (St Onge et al., 1997). (C) The full intron 7 construct 7CE1234-Z, (D) 7CE123-Z, (E)
7CE12-Z, the inset shows an E14.5 eye, (F) 7CE23-Z, (G) 7CE2-Z, (H) 7CE34-Z, and (I) 7CE1-Z. Abbreviations: D, diencephalon; R, rhombencephalon; H,
heart; LE, late eye. Restriction enzymes: A, Asp718I; Sm, SmaI; X, XbaI; S, SalI.
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ing, 7CE1-Z is shown to control expression in the eye after
E12.5 (Fig. 3I).
In conclusion, the total enhancer function of construct
7CE1234-Z can be accounted for by the additive combina-
tion of CE1, CE2, and CE3, as summarised in Fig. 3A. CE4
does not appear to have enhancer function in the embryo,
but we cannot exclude a role for this element duringpostnatal stages or some function that is not expressed as
positive enhancer activity.
Autoregulation of the CE2 enhancer in the diencephalon
The existence of Pax6 autoregulation in the dienceph-
alon was suggested by earlier work (Grindley et al., 1997),
and this led us to investigate what effect the absence of
Fig. 4. Pax6 autoregulation in the diencephalon. (A, left) Schematic map of an E10.5 embryo showing the arealisation of the forebrain into prosomeres. The
diencephalon (D) is made up of prosomeres P1, P2, and P3. M, midbrain; R, rhombencephalon; T, telencephalon. (A,C,E) Expression in diencephalon was
analysed in Pax6+/ and Pax6 / knock-in embryos, where LacZ expression is an indicator of expression from the endogenous Pax6 gene. Expression is
down-regulated in the prosomere P1 region of homozygous Pax6/LacZ (Pax6 / ) embryos, which lack functional Pax6, with the midbrain/diencephalon
boundary becoming fuzzy. (A, right) E10.5, coronal view; (C) E10.5, side view; (E) E11.5, side view. (B,D,F) Expression in diencephalon was compared
between 7CE1234-Z transgenic embryos on wild-type and homozygous Smalleye (Sey / ) backgrounds. In the absence of functional Pax6, expression is
lost after E9.5 in the prosomere 2 (P2) region of the diencephalon, while expression is maintained in prosomere P1. A sharp expression boundary is maintained
between the midbrain and P1 (B) E9.5, (D) E10.5, (F) E11.5. Note that the narrow stripe of expression at the base of the midbrain is maintained in both
Pax6 / and 7CE1234-Z embryos. (G) Comparison of expression driven by the C1170box123 enhancer on wild-type and Sey/Sey backgrounds at E11.5.
Expression in the P1 region is completely lost in the Sey/Sey embryo. (H) Comparison of EI enhancer activity on wild-type and Sey/Sey backgrounds. A severe
reduction in the level of expression in P1 is observed in the absence of functional Pax6.
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enhancer. Two independent transgenic lines, one for con-
struct 7CE1234-Z and one for 7CE123-Z, were crossedonto a Pax6 point mutant background. The strain used was
the Edinburgh Small eye mouse (Pax6SeyEd; denoted
hereafter Sey/+ for heterozygotes and Sey/Sey for homo-
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domain and homeodomain (Hill et al., 1991). Embryos
were analysed at E9.5, E10.5, and E11.5 from the follow-
ing crosses: 7CE1234-Z//Sey/+  Sey/+ and 7CE123-Z//
Sey/+  Sey/+. These were compared with embryos from
crosses between Pax6+/  Pax6+/ , where LacZ
expression is from LacZ inserted in frame into the endog-
enous Pax6 gene (St Onge et al., 1997). Reflecting the
known Pax6 pattern in wild-type embryos, heterozygous
Pax6+/ embryos express LacZ in all prosomeres (P1,
P2, and P3) of the diencephalon (Figs. 4A,C,E; embryos
on the right). In homozygous Pax6 / embryos, expres-
sion is reduced in P1, but appears to be maintained in P2
and P3 (Figs. 4A,C,E; embryos on the left). The same
altered pattern is observed by Pax6 RNA in situ hybrid-
isation in Sey/Sey embryos (Grindley et al., 1997; Warren
and Price, 1997). However, development of the dienceph-
alon is altered in Pax6 / and Sey/Sey embryos, such
that the prosomere identities may not be completely
equivalent to their wild-type/heterozygous counterparts.
As described above, the CE2 enhancer drives expression
in P1 and P2 of the diencephalon (Figs. 4B,D,F; embryos
on the right). Unexpectedly in 7CE1234-Z//Sey/Sey and
7CE123-Z//Sey/Sey embryos, we observed loss of enhanc-
er activity from E10.5 onwards in P2, rather than in P1
(Figs. 4B,D,F; embryos on the left). There is clear main-
tenance of a sharp boundary of LacZ expression between
P1 and the midbrain in the 7CE1234-Z//Sey/Sey embryos,
in contrast to the blurring of Pax6 expression at this
boundary in Pax6 / embryos (Figs. 4C,D; (Grindley
et al., 1997)). At E9.5, expression in P2 appears not yet
affected by the absence of functional Pax6, suggesting that
Pax6 is required for maintenance, but not initiation of
expression from the 7CE2 enhancer (Fig. 4B). As expected,
because heart does not normally express Pax6, the CE2-
driven heart pattern was unaltered between 7CE1234-Z//+/+
and 7CE1234-Z//Sey/Sey embryos. In conclusion, the pres-
ence of Pax6 is required for CE2 enhancer function in the
diencephalon, indicating the involvement of CE2 in an
autoregulatory loop.
Autoregulation of other diencephalon enhancers for Pax6
The unexpected finding that CE2 shows autoregulation
in prosomere P2 rather than in P1, led us to test whether
two other known enhancers for Pax6 expression in P1 are
subject to autoregulation. The enhancers C1170box123
(Griffin et al., 2002) and EI (Kleinjan et al., 2001) both
drive diencephalon expression solely in the P1 prosomere,
with additional expression at other sites in the embryo
(Figs. 4G,H). When crossed onto a homozygous Sey/Sey
background, both these enhancers lose their ability to
drive expression efficiently in the diencephalon, while
maintaining expression at other sites. For the
C1170box123 enhancer, diencephalic expression is com-
pletely abolished in the absence of Pax6, while expressionin a lateral stripe at the base of the midbrain is maintained
(Fig. 4G). Expression from the EI enhancer is severely
diminished on a Sey/Sey background, while being main-
tained in rhombencephalon (Fig. 4H). The missing lens
expression is due to the fact that no lens is formed in
small eye homozygotes.
Identification of a Pax6 binding site in CE2
To address whether the regulation by Pax6 is direct or
indirect, we scanned the conserved sequence of the CE2
enhancer for putative Pax6 binding sites. A sequence
matching 15 out of 17 nucleotides in the consensus Pax6
binding site (Czerny and Busslinger, 1995; Epstein et al.,
1994) was identified. It lies in the middle of a block that is
highly conserved between mouse, human, Fugu, and zebra-
fish Pax6a (Fig. 5A). A putative Pax6 binding site, match-
ing 14 out of 17 nucleotides, was also found in the EI
enhancer, but no obvious sites were found in the
C1170Box123 sequence.
To determine whether Pax6 protein binds to the sites
found in the CE2 and EI enhancers, we performed
electrophoretic mobility shift assays (EMSAs) using 36-
bp-long oligonucleotides corresponding to the putative
binding sites and surrounding sequences (Fig. 5B). La-
belled oligonucleotides were incubated with nuclear ex-
tract from ARPE cells (Dunn et al., 1996) as a source of
Pax6 protein. The Pax6 non-expressing cell line HT-29
was used as negative control. The double-stranded oligo-
nucleotide corresponding to the CE2 Pax6 binding site
and flanking sequences (CE2-oligo) formed a specific
complex with the ARPE extract (lane 2), which was
not seen with the HT-29 extract (lane 11). This complex
was sensitive to competition with excess cold oligonu-
cleotide (‘cold self’; lane 3) or with the canonical Pax6
consensus sequence (PAX6CON; lane 8), but not to
competition with an oligo containing a mutated binding
site (CE2mutated; lane 4). The complex was also com-
peted by a 100-bp fragment containing the CE2 Pax6
binding site in its wider genomic context (positions 297–
396 in Fig. 5A) (lane 5). A double-stranded oligo with
an artificially created Pax6 binding site (EI-Z-artif; lane
7) could also partially compete out the formation of a
Pax6–CE2 complex. The specificity of the interaction
between Pax6 and the CE2 binding site was demonstrated
by a supershift of the complex in the presence of anti-
Pax6 antibody (lane 10). In contrast, the double-stranded
oligonucleotide corresponding to the potential Pax6 bind-
ing site in the EI enhancer did not form a Pax6-contain-
ing complex upon incubation with ARPE nuclear extract
when used as probe (data not shown). Excess of the EI
oligo also failed to compete out the formation of the
CE2–Pax6 complex (EI-Z-oligo; lane 6), indicating that
the putative Pax6 binding site in EI is at most a very
weak one. Taken together, these results show that Pax6
can directly interact with a binding site in the CE2
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of this element.
Identification of a novel Pax6 transcript
As specific enhancer function was not identified for
the CE4 element, we set out to assess whether it has
some other role. Among possible non-enhancer functions,
we decided to investigate whether it might be part of an
alternative Pax6 transcript. The existence of an alternative
Pax6 RNA transcript, lacking the paired box, has been
demonstrated in C. elegans, where this isoform is impli-
cated in the mab-18 mutants at the Pax6 locus (Zhang
and Emmons, 1995) while the conventional transcript is
altered in the vab-3 mutants (Chisholm and Horvitz,
1995). A similarly derived gene product has also been
suggested in quail, where shorter Pax6 protein isoforms
were identified by Western blotting (Carriere et al., 1993).
Theoretically, a Pax6 isoform lacking the paired box can
be made with translation starting at a methionine in exon
8, just before the homeodomain, giving rise to a protein
of 221 amino acids.
To determine whether such alternative Pax6 isoforms
are transcribed, we performed RT-PCR (34 cycles) on
RNA from various Pax6-expressing and non-expressing
cell lines and from E11.5 mouse embryos, using primers
Pr205 in CE4 and Pr050 in exon 9 (Fig. 6A). A novel
Pax6 transcript, including the conserved CE4 region of
intron 7, was observed (Fig. 6B). Surprisingly, the tran-
script was also detected with primers Pr204 and Pr050
(not shown), indicating that a transcription start site lies
upstream of CE4. Sequence analysis of the human PAX6
locus had previously indicated the presence of an internal
CpG island in intron 7, and this was shown to be a true
CpG island using a methyl CpG binding column (Cross et
al., 1999). This CpG island is located in the region of
CE1. An RT-PCR product was detected with primers
Pr247/Pr248 specific for CE1, suggesting that it is part
of the alternative Pax6 transcript (Fig. 6B). No product
was found with primer pairs between either exon 6 and
CE1 or exon 7 and CE1 (not shown), suggesting that the
transcript is not an unspliced product. Controls were run
using primer pairs Pr049/Pr050 (specific for regular Pax6
mRNA) and Pr087/Pr088 (specific for the ubiquitously
expressed neighbouring ELP4 gene (Kleinjan et al., 2002;
Winkler et al., 2001).Fig. 5. Identification and analysis of a conserved Pax6 binding site in the 7CE2 en
showing several highly conserved blocks of sequence between human, mouse, Fu
human, mouse, and zebrafish Pax6a are shown as dark grey boxes, and mouse–hum
Sequences of the oligonucleotides used in the bandshift assay are below the multip
to the consensus Pax6 binding sequence. (B) Bandshift assay using the CE2-oligo
2–10) or the non-expressing HT-29 (11). Lane 1: no extract added; lane 2: ARPE e
were added: lane 3: CE2-oligo (‘self’), lane 4: 100 bp fragment 7CE2, lane 5: CE
non-specific other (LoxP-oligo), lane 10: anti-Pax6 antibody. In lane 11, the probe
non-specific, and supershifted bands are indicated on the right of the gel.To confirm that the transcript is not an alternatively
spliced regular PAX6 product, but initiates at a novel start
site near CE1, we performed RT-PCR on RNA from
E11.5 homozygous Pax6 / embryos, in which the
genomic sequence from exon 4 to intron 6 has been
replaced by a LacZ/Neo cassette (St Onge et al., 1997).
RT-PCR with primers for regular Pax6 (Pr049/Pr050)
shows absence of Pax6 expression in Pax6 / embry-
os, while control RT-PCR with Elp4 primers (Pr087/
Pr088) shows expression of this ubiquitously expressed
gene in both wild-type and Pax6 / embryos. RT-PCR
with primers for the novel transcript (Pr205/Pr050) indi-
cates that this transcript is expressed in Pax6 /
embryos, albeit at lower level than in wild-type embryos
(Fig. 6C). The novel PAX6 transcript, unlike the ubiqui-
tously expressed ELP4 gene, is observed only in Pax6-
expressing cells (Figs. 6B,C). Interestingly, the Pr205/
Pr050 primer pair (Fig. 6C) detects isoforms that are
both spliced and unspliced for intron 8.
The relative expression level of the transcript was
determined using a semi-quantitative RT-PCR assay with
total RNA from CE11560 cells. Samples from the same
mastermix were subjected to increasing rounds of ampli-
fication with primers Pr049/Pr050 specific for regular
PAX6 mRNA, or Pr261/Pr262 for the intron 7-containing
transcript. The number of amplification rounds required to
obtain bands of equal, non-saturation intensity was com-
pared (Fig. 6D). From this, it is estimated that in this cell
line, the novel transcript is expressed at about 1% of the
level of regular PAX6.
In silico analysis of intron 7 genomic sequence predicts
the novel mRNA to have a length of 7.5 kb. Northern
analysis of PAX6-expressing cell lines reveals a band at
7.5 kb in addition to the strong signal at 2.7 kb, the length
of the regular PAX6 mRNA (Fig. 6E). The band is not
observed in the non-PAX6-expressing cell lines on the
blot.
Finally, to determine the exact transcription initiation
site for the novel transcript, a primer extension assay was
carried out using antisense primer Pr256, located in CE1.
This revealed an extension product of 160 bp in
CE11560, ARPE, and E11.5 mouse whole embryo
RNA. The sequence ladder of mouse intron 7 running
alongside the primer extension product indicates that the
start site is a C at 839 bp downstream of the exon 7
border.hancer. (A) Multiple sequence alignment of the core of the 7CE2 enhancer
gu, and zebrafish Pax6a (black boxes). Sequences conserved only between
an conservation as light grey. The conserved Pax6 binding site is indicated.
le alignment. Grey shading indicates positions where the sequence confirms
as probe and nuclear extract from the Pax6-expressing cell line ARPE (lanes
xtract only. In lanes 3–10, extract plus the following unlabeled competitors
2mutated, lane 6: EI-Z-oligo, lane 7: EI-Z-artif, lane 8: Pax6CON, lane 9:
was incubated with HT-29 extract only. The positions of the Pax6 specific,
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Intronic sequence similarity among vertebrates identifies
functional regulatory elements
The importance of correct PAX6 expression levels at
precise spatiotemporally defined locations is well established
for eye development: both haplo-insufficiency and overex-
pression are known to lead to congenital eye anomalies (Hill
et al., 1991; Schedl et al., 1996; Ton et al., 1991). Increas-
ingly, it is recognised that brain development is also affected
not only by complete loss of Pax6 function, but also by Pax6
haploinsufficiency (Estivill-Torrus et al., 2001; Sisodiya et
al., 2001). The evolutionary sequence conservation of non-
coding region regulatory elements is becoming a well-estab-
lished finding using mammalian and wider vertebrate com-
parisons (Elgar et al., 1996; Pennacchio and Rubin, 2001;
Waterston et al., 2002). As the pivotal role of Pax6 in eye and
CNS development was established very early in evolution, it
is not surprising that the cis-acting elements controlling Pax6
transcription are conserved. Comparison of the human PAX6
locus with pufferfish (Miles et al., 1998) revealed the pres-
ence of three conserved elements, CE1, CE2, and CE3, in
intron 7 of the gene.When human and mouse sequences were
compared, a fourth highly conserved element was found. This
fourth element, CE4, appears specific for mammalianPax6 as
it is also found in primates, cat, and cow, but absent from
zebrafish and Fugu.
To explore the role of these conserved elements, we
produced a series of transgenic mice using a minimal pro-
moter-LacZ reporter cassette. Transgenic embryos carrying
the full intron 7 construct show a complex pattern of
expression in diencephalon, rhombencephalon, heart, and
also in the eye but only from E12.5 onwards. The dienceph-
alon, rhombencephalon, and late eye form a subset of the
endogenous Pax6 expression domains. However, heart ex-
pression is unexpected as Pax6 is not normally found there.
Systematic deletion analysis of the conserved elements
revealed that the activity generating expression in the heart
resides in CE2, which also harbours the diencephalon activ-
ity. In silico analysis of the CE2 sequence reveals a number of
potential binding sites for Nkx2.5 and GATA, transcriptionFig. 6. Identification of an alternative PAX6 transcript starting in intron 7. (A) Struc
grey boxes indicate the exons. Positions of the conserved elements are marked as
indicated. Positions of the primers used for RT-PCR are shown below the locus. Th
Pr205/Pr050 are shown. (B) RT-PCR analysis of transcripts containing intron 7 seq
cell lines, as well as in RNA from an E11.5 embryo. Primer pairs are indicated next
indicate presence or absence of reverse transcriptase in the RT reactions. (C) R
presence of the alternative transcript (Pr205/Pr050) in the Pax6 null embryos, whil
RT-PCR to determine the relative levels of alternative to regular PAX6 transcripts.
of PCR product for the alternative transcript. (E) Northern blot of human cell line
addition to the strong expression of the known 2.7-kb PAX6 mRNA in three hum
observed in the non-expressing cell lines A172 (glioblastoma), K562 (erythroleu
(colon carcinoma). (F) The transcriptional start site of the transcript was mapped
(human pigment epithelium), CE11560 (human lens epithelium), and E11.5 mous
and a sequencing ladder of mouse sequence are shown.factors with established roles in heart development. It is
conceivable that the same combination of factors required
to activate the CE2 enhancer in diencephalon is also present
in the developing heart, leading to the activation of the
isolated transgenic enhancer in both these structures. How-
ever, it is likely that in the context of the intact endogenous
Pax6 locus, CE2 is subject to negative regulation in the heart,
but not in diencephalon. Because heart expression was seen
both with isolated CE2 and with the full intron 7 construct,
this repressor function must require interaction with a cis-
acting component outside intron 7. Alternatively, in the
endogenous locus, the CE2 element may not be able to
perform its enhancer function in the developing heart where
the Pax6 locus is expected to be in a closed, repressive
chromatin state. Neither of these arrangements is likely to
be recreated when the isolated element integrates as a trans-
gene at random sites in the mouse genome.
Zebrafish has two pax6 homologues, pax6a and pax6b,
as a result of ancient chromosomal duplication in the
zebrafish lineage. We sequenced intron 7 of both homo-
logues and found that CE1 and CE3 are present in both
pax6a and pax6b at similar or higher levels of conserva-
tion than in Fugu, while CE2, though clearly present in
pax6a, is not identifiable in pax6b. pax6a and pax6b have
partly overlapping, but clearly distinct expression patterns;
interestingly, both genes are expressed in diencephalon at
early stages, but only Pax6a maintains widespread ex-
pression at later stages (Nornes et al., 1998). pax6b
expression becomes limited to a thin stripe at the border
with the midbrain. It is therefore of particular interest that
the CE2 element drives reporter gene expression in the
diencephalon (Fig. 3G), and that Pax6 autoregulation
appears to be involved in its maintenance. Loss of the
CE2 enhancer from the Pax6b intron 7 sequence corre-
lates with the divergence of pax6a and pax6b expression
patterns.
Two other conserved elements reveal enhancer function:
CE1 in control of late eye expression and CE3 in the
developing hindbrain. CE4, however, does not drive report-
er expression during embryonic development, although a
role in adult tissues cannot be excluded. Alternatively, there
may be requirement for interaction with another moreture of the genomic Pax6 locus with the intron 7 region enlarged. Numbered
differently shaped boxes. The CpG island around conserved element CE1 is
e RT-PCR sizes of the spliced and genomic/unspliced products with primers
uences in PAX6-expressing (ARPE, CE11560) and non-expressing (HT-29)
to the gel and their positions are shown in A. + and  signs above the lanes
T-PCR analysis on wild-type and Pax6 / mutant embryos shows the
e the regular Pax6 transcript (Pr049/Pr050) is absent. (D) Semi-quantitative
An additional eight cycles of PCR are required to obtain a comparable level
s probed with a PAX6 cDNA probe shows a longer transcript of 7.5 kb in
an lens epithelium cell lines, MACK, CD5a, and MAC67. The band is not
kemia), HL60 (myeloid leukemia), CCRF-CEM (T-cell leukemia), HT29
by primer extension. Fifty micrograms of total RNA from cell lines ARPE
e embryo was hybridized to radiolabeled primer Pr256. Extension products
D.A. Kleinjan et al. / Developmental Biology 265 (2004) 462–477474distant cis-element. The full intron 7 enhancer activity can
be recapitulated additively by the isolated components CE1,
CE2, and CE3, with no evidence of synergistic interaction
between them.
Complete functional definition of regulatory elements is
difficult, owing to the interactive nature of their endogenous
in vivo role. Putative control regions have been studied
using different approaches: (i) differential chromatin analy-
sis using either DNase I hypersensitivity in expressing
tissues (Kleinjan et al., 2001) or footprinting analysis to
identify transcription factor binding (Tagoh et al., 2002); (ii)
transgenic reporter analysis (Kleinjan et al., 2001; Loots et
al., 2000); and (iii) targeted deletion studies (Baumer et al.,
2002; Dimanlig et al., 2001; Marquardt et al., 2001; Mohrs
et al., 2001). Each of these approaches assesses the role of
the regulatory element in isolation, so that cooperative
interactions are destroyed, leading to potential discrepancies
between the different approaches (Beckers and Duboule,
1998). More holistic approaches that allow the study of
long-range in vivo regulatory interactions in the endogenous
locus are being developed (Carter et al., 2002; Tolhuis et al.,
2002).
Autoregulation of intron 7 elements by Pax6
Pax6 autoregulation in the posterior diencephalon was
suggested by RNA in situ analysis in Pax6-null embryos
(Grindley et al., 1997). Pax6 mRNA is lost from the
prosomere P1 (caudal) region of the diencephalon in Sey/
Sey mice. This is accompanied by a partial loss of P1
regional identity in these mice, and a blurring of the P1–
P2 boundary with enlargement of the zona limitans (the
region between prosomeres P2 and P3). The same can be
seen more readily in homozygous Pax6/LacZ knock-in
mice (see Fig. 4C) (St Onge et al., 1997). To test whether
CE2 is involved in diencephalic autoregulation, we
crossed two of our transgenic lines onto a Small eye
background. Surprisingly, we found the opposite staining
pattern in CE2 transgenic//Sey/Sey embryos: CE2-driven
LacZ expression, was maintained in the P1 region, but no
longer detected in the P2 region. Thus the activity of the
CE2 enhancer appears to be independent of Pax6 in P1,
but dependent on Pax6 in P2. We identified a Pax6
binding site in CE2 and show that this site binds Pax6
in a bandshift assay, indicating that the autoregulation is
direct. How the difference in autoregulation between the
P1 and P2 regions of the diencephalon is achieved
remains unclear, but is presumably dependent on differ-
ences in expression of other regulatory factors. Two other
recently identified Pax6 enhancer elements can drive
expression in the P1 region of the diencephalon (Griffin
et al., 2002; Kleinjan et al., 2001). We find both of these
strongly down-regulated when crossed onto a homozy-
gous Sey/Sey background. However, direct regulation by
Pax6 binding cannot be demonstrated for these elements.
A potential Pax6 binding site in EI failed to bind Pax6and no binding site could be recognised in element
C1170box123, suggesting that autoregulation of Pax6 in
prosomere P1 is indirect or requires a co-factor not
present in our nuclear extracts.
Here we have studied the enhancer function of single,
isolated elements integrated at random into the genome. The
effect of (auto)regulation in the endogenous locus, however,
must be a function of the combination of the various elements
and will therefore be much more complex and interactive.
This can explain deviations from the endogenous Pax6
pattern that may be elicited by individual elements. The
combined effect of autoregulation on the three diencephalon
enhancers may add up to a reduced expression, but not
absence, of Pax6 in prosomere P1, as seen for endogenous
Pax6. The endogenous level of expression in P2 appears
much less affected by the absence of functional Pax6 protein,
suggesting the existence of so far undiscovered Pax6-inde-
pendent P2 enhancers within the Pax6 locus. Although it is
assumed that in heterozygous Pax6+/ knock-in mice the
reporter gene is expressed identically to wild-type mRNA,
there is possibly subtle variation in Pax6 mRNA and protein
expression under conditions of haploinsufficiency, which is
the relevant situation in patients with aniridia for example. It
is therefore not surprising that careful analysis of brain
phenotype in such individuals is revealing clear structural
deviations from normal, such as absence of the anterior
commissure (Sisodiya et al., 2001) and absence of the pineal
(Mitchell et al., 2003).
Autoregulation, as well as cross-regulation by other
transcription factors is a major component of the mech-
anism for transcriptional control during development, the
cell cycle, differentiation, and response to environmental
challenge. Examples of carefully dissected facets of
autoregulatory control are accumulating (Trieu et al.,
2003). However, it is clear from early work in yeast
(Lee et al., 2002) that the pathways of regulation in
higher eukaryotes will emerge as much more complex
and subtle networks than we envisage from current
deconstructionist approaches.
Identification of a novel PAX6 transcript
The most highly conserved, mammalian-specific, in-
tron 7 element, CE4, failed to show enhancer activity in
the transgenic reporter assay. Enhancer function in some
adult tissues is possible as transgene analysis was con-
fined to embryonic stages. However, the absence of an
obvious enhancer role for CE4 led us to investigate
whether it might be part of an alternative transcript that
would give rise to a PAX6 isoform missing the paired
box. Such a transcript has been described in C. elegans.
The regular form of pax6, containing both paired and
homeodomains, constitutes the genetic locus vab-3 (var-
iable abnormal-3) which is involved in head region
development (Chisholm and Horvitz, 1995). In contrast,
the physically coincident, mutation-defined mab-18 (male
D.A. Kleinjan et al. / Developmental Biology 265 (2004) 462–477 475abnormal-18) locus encodes a pax6 isoform transcribed
from an internal promoter, lacks the paired domain, and
is required for the correct specification of a peripheral
male-specific sense organ (Zhang and Emmons, 1995).
The internal promoter from which that transcript initiates
is located in the C. elegans equivalent of intron 7.
Paired-less Pax6 isoforms have also been identified in
quail, where Western blotting of neuroretina extracts
using antibodies against the homeo- or transactivation
domains revealed the presence of shorter protein isoforms
which were not detected using antibodies to the paired
domain (Carriere et al., 1993). The molecular weight of
these isoforms suggested that they start from a methio-
nine in exon 7, and could be the product of a transcript
generated from the alpha enhancer/promoter (Kammandel
et al., 1999). We present evidence for the existence of an
alternative PAX6 transcript initiating from a CpG island
in intron 7 of the gene. Translation of this isoform using
a potential start codon in exon 8 could generate a protein
with a molecular weight of 25 kDa. Recently, a paired-
less Pax6 isoform, generated from a different, alternative-
ly spliced transcript, with the same predicted 221 amino
acid sequence, was described (Mishra et al., 2002), and
the translated product was shown to be stable. The N-
terminally truncated protein failed to bind either paired-
or homeodomain DNA binding sites, leaving the question
of function unresolved.
Our RT-PCR and Northern blot analyses clearly suggest
that the alternative message is only present where the full
Pax6 transcript is expressed, in PAX6-expressing cell lines
derived from lens epithelium, from retinal pigment epithe-
lium, and E11.5 whole embryo, but not from HT29 colon
carcinoma and other non-expressing cells. In all cases, the
alternative transcript is a minor component of the total
PAX6 transcription. Intriguingly, we observe both spliced
and unspliced transcripts with primer pairs that include an
intron. No C-terminal antibodies were available to look for
a translated product and we cannot exclude the possibility
that the alternative transcript fulfils some regulatory role at
the RNA level.
The separate and combined roles of the paired domain
and homeodomain are not yet clearly understood for Pax6
and related genes. It is established that although truncation
mutations are found throughout the gene in human aniridia
and Small eye mice, these mutations are generally thought
to lead to haploinsufficiency. Most missense mutations in
aniridia are in the paired domain (van Heyningen and
Williamson, 2002). In Drosophila, there is a suggestion that
the homeodomain is not required for the generation of
ectopic eyes (Punzo et al., 2001). These results may provide
an opportunity to explore the role of N-terminally truncated
Pax6 proteins.
The discovery of many new facets of Pax6 gene regula-
tion through detailed study of one conserved intron provides
further insight into the pleiotropic molecular mechanisms of
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